
Introduction
Peptides are widely studied in laboratory settings for their involvement in cellular signaling, protein interactions, and metabolic regulation. Their relevance spans multiple areas of scientific investigation, including cell culture models, biochemical pathway analysis, and preclinical research.
It is important to note that compounds discussed in this article are intended strictly for research use only (RUO) and are not approved for human or veterinary use by regulatory authorities such as the U.S. Food and Drug Administration (FDA).
This overview highlights several compounds frequently referenced in scientific literature, focusing on mechanistic observations and experimental contexts, without implying clinical or therapeutic application.
1. BPC-157
BPC-157 is a synthetic peptide fragment derived from a gastric protein sequence. It has been examined in preclinical models for its interaction with angiogenic signaling pathways and cellular response mechanisms.
Research focus areas:
- Cellular migration and signaling pathways
- Angiogenesis-related processes in experimental models
- Tissue-response signaling in controlled environments
2. TB-500 (Thymosin Beta-4 Fragment)
TB-500 is a synthetic fragment of Thymosin Beta-4, a naturally occurring peptide involved in actin regulation. Research has explored its role in cytoskeletal organization and cellular motility.
Research focus areas:
- Actin-binding and cytoskeletal dynamics
- Cell migration pathways
- Tissue remodeling signaling models
3. CJC-1295 (MOD GRF 1-29)
CJC-1295 is a synthetic analog of growth hormone–releasing hormone (GHRH). It has been studied in controlled settings for its interaction with the growth hormone regulatory axis.
Research focus areas:
- GH/IGF-1 axis signaling
- Receptor-mediated endocrine pathways
- Dose-response relationships in experimental settings
4. Ipamorelin
Ipamorelin is a selective ghrelin receptor agonist studied for its receptor-binding specificity. Research has examined its interaction with growth hormone secretagogue receptors (GHS-R1a).
Research focus areas:
- Ghrelin receptor selectivity
- Hormonal signaling pathways
- Endocrine modulation in controlled environments
5. MK-677 (Ibutamoren)
MK-677 is a non-peptide compound that mimics ghrelin activity. It is commonly studied alongside peptide-based secretagogues due to its effect on hormone signaling pathways.
Research focus areas:
- GH and IGF-1 pathway interaction
- Oral secretagogue mechanisms
- Long-term signaling modulation in experimental models
6. Follistatin-344
Follistatin is a glycoprotein that binds to and inhibits members of the TGF-β superfamily, including myostatin. It is studied for its role in protein-binding regulation and signaling inhibition.
Research focus areas:
- Myostatin inhibition pathways
- TGF-β signaling interactions
- Regulation of protein expression in laboratory models
7. AOD-9604
AOD-9604 is a modified fragment of human growth hormone. Research has focused on its interaction with lipid metabolism pathways independent of full-length HGH activity.
Research focus areas:
- Lipolysis-related signaling
- Metabolic pathway modulation
- Energy regulation mechanisms in vitro and in vivo models
8. MOTS-c
MOTS-c is a mitochondrial-derived peptide encoded within mitochondrial DNA. It has been studied for its role in cellular energy regulation and metabolic signaling.
Research focus areas:
- AMPK pathway activation
- Mitochondrial signaling
- Cellular stress-response mechanisms
9. PEG-MGF (Pegylated Mechano-Growth Factor)
MGF is an isoform of IGF-1 associated with mechanical stimulus response in experimental models. Pegylation extends its stability for research applications.
Research focus areas:
- IGF-1 splice variant signaling
- Cellular response to mechanical stress
- Satellite cell signaling pathways
Quality and Research Standards
In laboratory research, compound quality, traceability, and verification are critical for reproducibility and data integrity.
Key considerations include:
- Certificate of Analysis (COA) verification
- Analytical testing (e.g., HPLC, LC-MS)
- Batch consistency and traceability
- Controlled storage and handling conditions
All materials referenced are intended strictly for in vitro or laboratory research applications and must be handled in accordance with applicable regulations.
Conclusion
Peptides and related compounds continue to be studied for their roles in cellular communication, metabolic regulation, and biochemical signaling pathways. While research findings contribute to scientific understanding, these compounds are not approved for therapeutic, diagnostic, or performance-related use in humans or animals.
Maintaining a strict research-use framework ensures compliance, safety, and scientific integrity across all applications.
FAQ
1. Are these compounds approved for human use?
No. These materials are not FDA-approved and are intended strictly for research use.
2. What does “research use only” mean?
It means the compounds are intended solely for laboratory research and not for human or veterinary application.
3. Why is COA verification important?
COAs confirm identity and purity, which are essential for reproducible research outcomes.
4. Can these compounds be used outside a lab setting?
No. They are restricted to controlled research environments.
5. What type of research are these used for?
They are commonly used in biochemical, cellular, and preclinical experimental models.
References
- https://pubmed.ncbi.nlm.nih.gov/25801854/
- https://pubmed.ncbi.nlm.nih.gov/17145551/
- https://pubmed.ncbi.nlm.nih.gov/16492811/
- https://pubmed.ncbi.nlm.nih.gov/14523039/
- https://pubmed.ncbi.nlm.nih.gov/12840149/
- https://pubmed.ncbi.nlm.nih.gov/21996836/
- https://pubmed.ncbi.nlm.nih.gov/36761202/
- https://pubmed.ncbi.nlm.nih.gov/19077676/
- https://pubmed.ncbi.nlm.nih.gov/14576440/
Research Use Only Notice:
This material is intended solely for laboratory research purposes. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Any referenced findings are derived from preclinical (in vitro or animal) studies and do not represent established clinical outcomes.